Provided By PR Newswire
Last update: Dec 20, 2022
Cites Large, Unserved Needs of Sickle Cell Disease Patients
TORRANCE, Calif., Dec. 20, 2022 /PRNewswire/ -- Emmaus Life Sciences, Inc. (OTCQX: EMMA), announced today that Dr. Yutaka Niihara, Chairman and Chief Executive Officer of the company, was hosted in Mumbai, India on December 16, 2022 by Bhagat Singh Koshyari, the Governor of the State of Maharashtra, the industrial, financial and commercial center of India. In remarks on social media, https://t.co/vTrKwVT4if, the Governor cited the more than 20 million people suffering from sickle cell disease (SCD) in his country and spoke of the discovery of EndariĀ® that can help patients with SCD.
Read more at prnewswire.com